240 related articles for article (PubMed ID: 12885891)
1. Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin.
Yoshida A; Tanaka R; Murakami T; Takahashi Y; Koyanagi Y; Nakamura M; Ito M; Yamamoto N; Tanaka Y
J Virol; 2003 Aug; 77(16):8719-28. PubMed ID: 12885891
[TBL] [Abstract][Full Text] [Related]
2. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y
Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
[TBL] [Abstract][Full Text] [Related]
3. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha.
Lapenta C; Santini SM; Logozzi M; Spada M; Andreotti M; Di Pucchio T; Parlato S; Belardelli F
J Exp Med; 2003 Jul; 198(2):361-7. PubMed ID: 12874266
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
Fais S; Lapenta C; Santini SM; Spada M; Parlato S; Logozzi M; Rizza P; Belardelli F
J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739
[TBL] [Abstract][Full Text] [Related]
5. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
Mosier DE; Gulizia RJ; MacIsaac PD; Corey L; Greenberg PD
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2443-7. PubMed ID: 8460155
[TBL] [Abstract][Full Text] [Related]
6. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.
Santini SM; Lapenta C; Logozzi M; Parlato S; Spada M; Di Pucchio T; Belardelli F
J Exp Med; 2000 May; 191(10):1777-88. PubMed ID: 10811870
[TBL] [Abstract][Full Text] [Related]
7. T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.
Rizza P; Santini SM; Logozzi MA; Lapenta C; Sestili P; Gherardi G; Lande R; Spada M; Parlato S; Belardelli F; Fais S
J Virol; 1996 Nov; 70(11):7958-64. PubMed ID: 8892919
[TBL] [Abstract][Full Text] [Related]
8. High titer, prostate specific antigen-specific human IgG production by hu-PBL-SCID mice immunized with antigen-mouse IgG2a complex-pulsed autologous dendritic cells.
Coccia MA; Brams P
J Immunol; 1998 Nov; 161(10):5772-80. PubMed ID: 9820559
[TBL] [Abstract][Full Text] [Related]
9. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
10. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.
Lapenta C; Santini SM; Spada M; Donati S; Urbani F; Accapezzato D; Franceschini D; Andreotti M; Barnaba V; Belardelli F
Eur J Immunol; 2006 Aug; 36(8):2046-60. PubMed ID: 16856207
[TBL] [Abstract][Full Text] [Related]
11. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
[TBL] [Abstract][Full Text] [Related]
12. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
Kim KC; Choi BS; Kim KC; Park KH; Lee HJ; Cho YK; Kim SI; Kim SS; Oh YK; Kim YB
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):194-202. PubMed ID: 26564392
[TBL] [Abstract][Full Text] [Related]
13. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
[TBL] [Abstract][Full Text] [Related]
14. hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120.
Safrit JT; Fung MS; Andrews CA; Braun DG; Sun WN; Chang TW; Koup RA
AIDS; 1993 Jan; 7(1):15-21. PubMed ID: 7680205
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
Berges BK; Wheat WH; Palmer BE; Connick E; Akkina R
Retrovirology; 2006 Nov; 3():76. PubMed ID: 17078891
[TBL] [Abstract][Full Text] [Related]
16. Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice.
Miura Y; Misawa N; Maeda N; Inagaki Y; Tanaka Y; Ito M; Kayagaki N; Yamamoto N; Yagita H; Mizusawa H; Koyanagi Y
J Exp Med; 2001 Mar; 193(5):651-60. PubMed ID: 11238596
[TBL] [Abstract][Full Text] [Related]
17. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
18. Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1.
Marusic C; Rizza P; Lattanzi L; Mancini C; Spada M; Belardelli F; Benvenuto E; Capone I
J Virol; 2001 Sep; 75(18):8434-9. PubMed ID: 11507188
[TBL] [Abstract][Full Text] [Related]
19. Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.
Bahr GM; Darcissac EC; Castéran N; Amiel C; Cocude C; Truong MJ; Dewulf J; Capron A; Mouton Y
J Virol; 2001 Aug; 75(15):6941-52. PubMed ID: 11435574
[TBL] [Abstract][Full Text] [Related]
20. Development of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models.
Okada M; Takemoto Y; Okuno Y; Hashimoto S; Fukunaga Y; Tanaka T; Kita Y; Kuwayama S; Muraki Y; Kanamaru N; Takai H; Okada C; Sakaguchi Y; Furukawa I; Yamada K; Izumiya M; Yoshida S; Matsumoto M; Kase T; Peiris JS; DeMello DE; Chen PJ; Yamamoto N; Yoshinaka Y; Nomura T; Ishida I; Morikawa S; Tashiro M; Sakatani M
Adv Exp Med Biol; 2006; 581():561-6. PubMed ID: 17037598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
